Akoya Biosciences Valuation
Akoya Biosciences seems to be undervalued based on Macroaxis valuation methodology. Our model approximates the value of Akoya Biosciences from analyzing the firm fundamentals such as Return On Equity of -1.8, profit margin of (0.68) %, and Current Valuation of 132.39 M as well as examining its technical indicators and probability of bankruptcy.
Akoya Biosciences Total Value Analysis
Akoya Biosciences is presently anticipated to have valuation of 132.39 M with market capitalization of 83.28 M, debt of 7.96 M, and cash on hands of 87.61 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Akoya Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
132.39 M | 83.28 M | 7.96 M | 87.61 M |
Akoya Biosciences Investor Information
About 67.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.16. Akoya Biosciences had not issued any dividends in recent years. Based on the key indicators related to Akoya Biosciences' liquidity, profitability, solvency, and operating efficiency, Akoya Biosciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Akoya Biosciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Akoya Biosciences has an asset utilization ratio of 65.33 percent. This suggests that the Company is making $0.65 for each dollar of assets. An increasing asset utilization means that Akoya Biosciences is more efficient with each dollar of assets it utilizes for everyday operations.Akoya Biosciences Ownership Allocation
Akoya Biosciences holds a total of 49.57 Million outstanding shares. Akoya Biosciences shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 67.21 percent of Akoya Biosciences outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Also note that nearly eighteen million three hundred fourty-six thousand eight hundred fifty-six invesors are currently shorting Akoya Biosciences expressing very little confidence in its future performance.Akoya Biosciences Profitability Analysis
The company reported the previous year's revenue of 81.67 M. Net Loss for the year was (55.37 M) with profit before overhead, payroll, taxes, and interest of 47.88 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Akoya Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Akoya Biosciences and how it compares across the competition.
About Akoya Biosciences Valuation
The stock valuation mechanism determines Akoya Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Akoya Biosciences. We calculate exposure to Akoya Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Akoya Biosciences's related companies.Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts. Akoya Biosciences operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 319 people.
Akoya Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 49.4 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Tools for Akoya Stock
When running Akoya Biosciences' price analysis, check to measure Akoya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akoya Biosciences is operating at the current time. Most of Akoya Biosciences' value examination focuses on studying past and present price action to predict the probability of Akoya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akoya Biosciences' price. Additionally, you may evaluate how the addition of Akoya Biosciences to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |